Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphomas

Jun 6, 2017 by in ONCOLOGY Comments Off on Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphomas

© Springer International Publishing Switzerland 2015Andrew M. Evens and Kristie A. Blum (eds.)Non-Hodgkin LymphomaCancer Treatment and Research16510.1007/978-3-319-13150-4_14 Allogeneic Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphomas Ibrahim Aldoss1 and Auayporn Nademanee1   (1) City of Hope National Medical Center,…

read more

Management of Peripheral T-Cell Lymphomas

Jun 6, 2017 by in ONCOLOGY Comments Off on Management of Peripheral T-Cell Lymphomas

T-cell prolymphocytic leukemia T-cell large granular lymphocytic leukemia Chronic lymphoproliferative disorder of NK cell Aggressive NK leukemia Systemic EBV-positive T-cell lymphoproliferative disorder of childhood Hydroa vaccineforme-like lymphoma Adult T-cell leukemia/lymphoma…

read more

of B-Cell Lymphomas: Diagnosis and Biomarker Discovery

Jun 6, 2017 by in ONCOLOGY Comments Off on of B-Cell Lymphomas: Diagnosis and Biomarker Discovery

  Expected immunophenotype Follicular lymphoma CD19+, CD20+, IgM ± IgD, monotypic sIg+, CD10+, bcl-6+, bcl-2 ±, HGAL, LMO2; associated with CD21+/CD23+ follicular dendritic cell meshworks Lymphoplasmacytic lymphoma CD19+, CD20+, monotypic sIg+, IgM, CD22+,…

read more

Strategies in Mantle Cell Lymphoma

Jun 6, 2017 by in ONCOLOGY Comments Off on Strategies in Mantle Cell Lymphoma

Fig. 1 Our approach to MCL treatment Table 1 Frontline regimens in patients ≤70 years Frontline regimen Age (years) ORR (%) PFS/FFS OS R-Hyper-CVAD [16] ≤81 97 3 years 64 % (≤65 3 years 73 %)…

read more
Get Clinical Tree app for offline access